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Background: Adherence to combination anti-retroviral therapy for HIV infection is a
primary determinant of treatment success, but is often suboptimal. Previous studies
have suggested that electronic medication monitoring-informed counseling is among the
most effective adherence intervention components. Our objective was to review available
evidence about the effectiveness of monitoring-informed counseling and to aggregate
findings into quantitative estimates of the effect of such intervention on medication
adherence and virologic treatment outcomes.
Methods: We searched PubMed for papers reporting on randomized controlled trials
comparing intervention groups receiving monitoring-informed counseling as one of the
intervention components versus control groups not receiving such counseling for their
effect on medication adherence and viral load concentrations. The standardized mean
difference (SMD) in adherence and the odds ratio (OR) of undetectable HIV RNA in
intervention versus control groups were the common effect sizes. Random-effect models
with inverse variance weights were used to aggregate findings into pooled effect estimates
with 95% confidence limits (CI).
Results: A total of 13 studies were included. Adherence was significantly higher in
intervention groups than in control groups (SMD 0.51, 95% CI 0.31–0.71). Patients
in intervention groups were significantly more likely to have undetectable HIV RNA
concentrations than patients in control groups (OR 1.35, 95% CI 1.12–1.63). However,
in studies in which monitoring-informed counseling was the only intervention component,
the difference in adherence and virologic response between intervention and control
groups was not statistically significant.
Conclusion: Electronic monitoring-informed counseling improved adherence and viro-
logic response compared with control groups not receiving such counseling in studies in
which it was one out of multiple intervention components, but not in studies where it was
the only intervention component.
Keywords: adherence, compliance, HIV infection, anti-retroviral therapy, meta-analysis
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Introduction
Adherence to combination anti-retroviral therapy (cART) is a
primary determinant of anti-retroviral treatment success. Suffi-
ciently high levels of adherence to cART are necessary to achieve
and sustain viral suppression and to prevent disease progression
and death (1–3). Yet, many HIV-infected patients do not succeed
in achieving or maintaining adequately high levels of adherence
to cART (4). Adherence to cART is potentially amenable to
intervention. Since the advent of cART, numerous interventions
aimed at enhancing adherence to cART have been developed and
evaluated. Several systematic reviews have reviewed and synthe-
sized the effectiveness of such interventions to improve adherence
and virologic treatment outcomes (5–8). Overall, these reviews
have shown that various types of interventions can significantly
increase adherence, but effects vary considerably across studies
and most types of interventions have also been found not to
produce significant effects in other studies.
An appreciable number of adherence-enhancing intervention
studies have provided patients and/or their health care providers
with objective information about the patients’ medication-taking
behavior as one of the intervention components. In these studies,
medication adherence is typically measured using an electronic
medicationmonitoring device. Electronic medicationmonitoring
devices register the time and date of each opening of the device,
which is assumed to represent medication ingestion. The date
and time of openings of the device over a long-time period can
be shown to patients in the form of a graphical display. Such
graphical feedback could make medication-taking behavior and
the occurrence of non-adherence more concrete or real to the
patient who may be unaware of suboptimal adherence. Person-
alized feedback based on the pattern of medication use could
open discussions between patients and health care providers about
adherence barriers and potential solutions to deal with these.
Research conducted across medical conditions have suggested
that feedback on adherence performance and the accompanying
counseling informed by recent adherence performance are among
the intervention components that improve adherence most con-
sistently (9–11). However, studies investigating the effectiveness
of such monitoring-informed counseling among patients with
chronic HIV infection have yielded inconsistent results. Some
studies (12) have found significantly improved adherence and
virologic treatment outcomes whereas others have found no ben-
eficial effects (13).
Our objective was to review available evidence about the effec-
tiveness of monitoring-informed counseling among patients who
are prescribed cART for a chronic HIV infection and to aggre-
gate findings into quantitative estimates of the effect of such
intervention on medication adherence and virologic treatment
outcomes. Moreover, we aim to identify study design features that
are associated with stronger intervention effects.
Materials and Methods
Literature Search
We searched PubMed for papers published from August 1996 to
October 2014 using the following strategy:
((“intervention” [tiab]) OR [“intervention” [tw])] AND
(HAART[title/abstract] OR CART[title/abstract] OR
ART[title/abstract] OR ARV[title/abstract] OR ARVs
[title/abstract] OR antiretroviral[title/abstract] OR
anti-retroviral[title/abstract] OR anti-viral[title/
abstract] OR antiviral[title/abstract] OR
“Antiretroviral Therapy, Highly Active”[Mesh]
OR “Anti-Retroviral Agents”[Mesh])) OR ((HIV
Infections[MeSH] OR HIV[MeSH] OR hiv[title/
abstract] OR hiv-1[title/abstract] OR hiv-2*[title/
abstract] OR hiv-1[title/abstract] OR hiv2[title/
abstract] OR hiv infect*[title/abstract] OR human
immunodeficiency virus[title/abstract] OR human
immune deficiency virus[title/abstract] OR human
immuno-deficiency virus[title/abstract] OR
human immune-deficiency virus[title/abstract]
OR [(human immun*) AND (deficiency virus[title/
abstract])] OR acquired immunodeficiency syndromes
[title/abstract] OR acquired immune deficiency
syndrome[title/abstract] OR acquired immuno-
deficiency syndrome[title/abstract] OR acquired
immune-deficiency syndrome[title/abstract] OR
((acquired immun*) AND (deficiency syndrome
[title/abstract])) or “sexually transmitted diseases,
viral”[mh]) OR HIV[title/abstract] OR HIV/AIDS
[title/abstract] OR HIV-infected[title/abstract] OR
HIV[title] OR HIV/AIDS[title] OR HIV-infected
[title])) AND (adhere*[tiab] OR complian*[tiab]
OR adhere*[tw] OR complian*[tw] OR Patient
Compliance[MeSH] OR Medication Adherence
[MeSH])) AND (“1996/01/01”[PDat]: “2014/12/
31”[PDat])))
The reference lists of the papers retrieved were reviewed for addi-
tional relevant publications. Additionally, we searched abstracts
from the International AIDS conference (years 2006, 2008, 2010,
2012, 2014), the IASConference onHIVPathogenesis, Treatment,
and Prevention (years 2007, 2009, 2011, 2013), the HIV Drug
Therapy Glasgow Meeting (years 2008, 2010, 2012, 2014), and
the International Conference on HIV Treatment and Prevention
Adherence (years 2010–2014).
Eligible studies met the following criteria: (1) randomized
controlled (cross-over) trial (2) comparing monitoring-informed
counseling as one of the intervention components versus not
receiving such counseling. Intervention groups could thus consist
of multi-component and single component interventions; (3) out-
comes aremedication adherence and/or viral load concentrations;
4) participants are HIV-infected persons prescribed cART for a
chronic HIV infection.We included English language papers only.
Data Extraction
We extracted the following information from each study: name of
the first author, year of publication, sample size, whether patients
were initiating, restarting, or switching a cART regimen or were
already on ART, whether the intervention was only administered
to patients with low pre-intervention adherence levels (yes/no), or
if patients were triaged to different levels of intervention intensity
depending on their adherence level (yes/no), the percentage of
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patients with undetectable viral loads at baseline, duration of
the intervention period (weeks), number of intervention sessions,
and intervention components. The categorization of intervention
components was adapted from two previous systematic reviews
of anti-retroviral adherence interventions (6, 8). Intervention
components additional to (1) monitoring-informed counseling
were coded as: (2) didactic provision of information about HIV,
cART, and adherence, (3) behavioral, cognitive behavioral, or
motivational counseling, (4) provision of reminder devices, (5)
social support enlistment, (6) depression screening, treatment,
or referral, (7) financial incentives for good adherence, and (8)
substance use screening, treatment, or referral. We calculated the
number of intervention components per study. Both authors inde-
pendently extracted information, and discrepancies were resolved
through discussion.Whenmore than one type of interventionwas
tested, data from each arm of the intervention were considered as
separate data points.
Statistical Analysis
We defined adherence as the percentage of prescribed doses of
cART taken. We used the standardized mean difference (SMD)
as the common effect size to express the difference in adherence
between intervention and control groups. If studies did not pro-
vide the SMD, we contacted authors to get additional data. If
no additional data were available, we calculated the SMD from
correlation coefficients, means and SDs, odds ratios (OR), t-, x2-,
orF-statistics, contingency table data, or exact p values (14).When
studies reported an insignificant effect on adherence without data,
we assigned a value to the SMD of 0.01. Values of the SMD of
0.2–0.49, 0.5–0.79, and0.8 can be interpreted as small, medium,
and large effects, respectively (15).
We used the OR as the common effect size to express the
difference in the percentage of patients with an undetectable viral
load in intervention versus control groups.When studies reported
an insignificant effect of the intervention on viral load without
data, we assumed an OR of 1.01. Random-effect models with
inverse variance weights were used to aggregate individual SMDs
and ORs into pooled effect estimates with 95% confidence limits
(CI) using Review Manager 5.3.
We compared pooled effect estimates of adherence and
undetectable viral loads between studies in which monitoring-
informed counseling was the only intervention component with
studies in which monitoring-informed counseling was one out
of multiple intervention components. We conducted a sensi-
tivity analysis to examine potential bias resulting from over-
representation of studieswithmore thanone intervention arm.We
examined the extent to which results would change when studies
with more than one intervention arm were excluded from the
analysis or if only a single intervention arm was included.
We examined whether variation in effect sizes of adher-
ence and viral load were significantly associated with study
design features. We investigated the effect of the following
study design features: whether patients were initiating, restart-
ing, or switching a cART regimen (yes/no) or were already on
ART, the percentage of patients with undetectable viral loads
at baseline, whether the intervention was only administered to
patients with low pre-intervention adherence levels (yes/no), or
if patients were triaged to different levels of intervention inten-
sity based on their adherence level (yes/no), duration of the
intervention period (weeks), number of intervention contacts,
whether intervention components administered to the interven-
tion group included the following: didactic provision of infor-
mation about HIV, cART, and adherence (yes/no), behavioral,
cognitive behavioral, or motivational counseling (yes/no), pro-
vision of reminder devices (yes/no), social support enlistment
(yes/no), depression screening/treatment/referral (yes/no), finan-
cial incentives for good adherence (yes/no), and substance use
screening/treatment/referral (yes/no).
Subgroup analysis were performed by grouping effect sizes for
adherence and viral load by study design feature and assessing
heterogeneity between groups using the between-groupQ statistic
(Q-between) within a mixed effects model using the method
of moments estimation. These analyses were conducted using
the SPSS macro’s MetaF and MetaReg from Lipsey and Wilson
(14, 16). We performed meta-regression analysis with method of
moment estimation to assess the relationship of the number of
intervention components per study with the SMD in adherence
and the log OR of undetectable HIV RNA using Comprehensive
Meta-Analysis version 2.We examined the presence of publication
bias by the visual inspection of funnel plot symmetry and formally
with Egger’s regression intercept.
Results
Our literature search yielded a total of 10,274 potentially relevant
articles. We found an additional article from another data source,
resulting in a total of 10,275 potentially relevant articles. All
articles were subsequently screened on the title and abstract. After
reading the full text of 67 articles, we excluded 54 articles mainly
because the intervention did not consist of monitoring-informed
counseling. Thus, a total of 13 articles, reporting on 1419 patients,
were found to meet inclusion criteria and were entered in our
meta-analysis (Figure 1). Characteristics of the included studies
are shown in Table 1. We contacted three authors, but could not
get any additional data.
Overall, we found that adherence was significantly higher in
intervention groups, which had received monitoring-informed
counseling as part of the intervention compared with control
groups that did not receive such counseling (SMD 0.51, 95%
CI 0.31–0.71) (Figure 2). This represents an improvement of a
moderate magnitude in terms of effect sizes. Moreover, patients in
these intervention groups were more likely to have undetectable
HIV RNA concentrations than patients in control groups that
did not receive such counseling (OR 1.35, 95% CI 1.12–1.63)
(Figure 3).
We identified three studies in which monitoring-informed
counseling was the single intervention component and was com-
pared with a control group not receiving such counseling (13,
14, 22). In these three studies, the effect of the intervention on
adherence (SMD 0.24, 95% CI  0.17 to 0.66) (Figure 2) and on
the likelihood of undetectable HIVRNA concentrations (OR 0.94,
95% CI 0.64–1.38) (Figure 3) was not statistically significant.
A total of 12 out 13 studies included compared a single inter-
vention arm with a control group. In one study, two intervention
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FIGURE 1 | Flow diagram.
arms were compared with the same control group (20). One of
the intervention arms of this study provided financial incentives
for good adherence in addition to the other intervention com-
ponents, whereas the other intervention arm did not provide
financial incentives. Excluding this study from our analysis or
including only the intervention arm without financial incentive
resulted in pooled effect estimates for adherence of SMD: 0.49
(95% CI 0.30–0.69) and SMD: 0.47 (95% CI 0.28–0.66), respec-
tively, and for the likelihood of achieving undetectable viral load
of OR: 1.37 (95% CI 1.13–1.66) and OR: 1.36 (95% CI 1.12–1.64),
respectively.
Variation in effect sizes of adherence were significantly asso-
ciated with the study design features; percentage of patients
with undetectable viral load at baseline and providing finan-
cial incentives for good adherence. Studies with a lower per-
centage of patients with undetectable viral loads at baseline
(dichotomized at the median of 35%) yielded larger effect sizes
than studies with a higher percentage of patients with unde-
tectable viral loads at baseline (SMD 0.65 versus 0.31, Q= 6.87,
p= 0.009). Studies providing financial incentives for good adher-
ence (22, 23) yielded larger effect sizes than studies without
financial incentives (SMD 1.32 versus 0.40, Q= 10.83, p= 0.001).
Both effects remained statistically significant in a multivariate
model.
Variation in effect sizes for undetectable viral loads were sig-
nificantly associated with whether the intervention components
included didactic provision of information about HIV, cART,
and adherence, or behavioral, cognitive behavioral, or motiva-
tional counseling. Studies in which the intervention compo-
nents included didactic provision of information about HIV,
cART, and adherence yielded higher effect sizes than studies not
including this intervention component (OR 1.81 versus OR 1.19,
Q= 9.91, p= 0.0016). Studies in which the intervention compo-
nents included behavioral, cognitive behavioral, or motivational
counseling yielded higher effect sizes than studies not including
this component (OR 1.64 versus OR 1.08, Q= 11.89, p= 0.0006).
We were unable to include both variables in a multivariate model
due to high collinearity.
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Davies et al (17) 145 No No – 1 48 –
de Bruin et al (12)* 133 No No** 84 1, 2, 3 36 4
Engelbrecht (18) 88 No No 69 1, 4 16 4
Gross et al (19)* 180 Yes No 0 1, 2, 3, 5, 6, 8 52 22
Koenig et al (20,21) 139 Yes No 0 1, 2, 3, 4, 5, 6, 8 24 11
Rigsby et al (22)* 55 No No 35 1, 3 4 5
1, 3, 7
Rosen et al (23)* 56 No Yes 57 1, 3, 7, 8 16 16
Sabin et al (24)* 64 No No** 88 1 24 6
Sabin et al (25)* 116 No No** 99 1, 4 24 6
Safren et al (26)* 45 No No – 1, 2, 3, 4, 6 48 10–12
Smith et al (27)* 43 Yes No 0 1, 2, 3, 5 12 4
Wagner et al (28)* 199 Yes No 15 1, 3 48 5
Wilson et al 2010 (13) 156 No No 0 1   2
(1) monitoring-informed counseling (2) didactic provision of information about HIV, cART and adherence; (3) behavioral, cognitive behavioral, or motivational counseling; (4) provision of
reminder device; (5) social support enlistment; (6) depression screening/treatment/referral; (7) financial incentives for good adherence; (8) substance use screening/treatment/referral.
*The study had reported significant improvement in adherence due to the intervention of interest. **Patients were triaged to different levels of intervention intensity depending on their
level of adherence.
FIGURE 2 | Effect of interventions on adherence.
Meta-regression analysis showed that a higher number of inter-
vention components were significantly associated with a higher
likelihood of undetectable HIV RNA (Figure 4), but not with
higher adherence in the intervention groups.
The funnel plot for the outcomemeasuremedication adherence
was suggestive of publication bias (Egger’s regression intercept
p= 0.04), with an absence of small studies yielding negative effects
(Figure 5). The funnel plot for the outcome measure virologic
treatment response was not suggestive of publication bias (Egger’s
regression intercept p= 0.99) (Figure 6).
Discussion
Our meta-analysis of randomized controlled trials (RCTs) inves-
tigating the effect of monitoring-informed counseling on treat-
ment adherence and virologic treatment response, yielded sig-
nificantly improved adherence and virologic treatment response
only when such counseling was part of a multi-component inter-
vention. The improvement in adherence constituted a medium-
sized effect. The improvement in medication adherence achieved
in the intervention groups was clinically relevant as it was
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FIGURE 3 | Effect of interventions on the likelihood of undetectable HIV RNA.
FIGURE 4 |Meta-regression of number of intervention components on the log odds of undetectable HIV RNA.
accompanied by an increased likelihood of having an undetectable
viral load.
We distinguished between studies in which monitoring-
informed counseling was the only intervention component and
studies in which monitoring-informed counseling was one out of
multiple intervention components. In the vast majority of studies
included, monitoring-informed counseling was one out of multi-
ple intervention components that patients received. Consequently,
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FIGURE 5 | Funnel plot medication adherence.
FIGURE 6 | Funnel plot undetectable HIV RNA.
the separate contribution of monitoring-informed counseling to
the improved levels of adherence and virologic treatment response
is difficult to establish. However, this reflects the current state
of the art in HIV adherence support research in which most
interventions consist of multiple components (29). Moreover, it
reflects the clinical reality that adherence is behavior that may
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be affected by multifactorial barriers that may best be addressed
by comprehensive interventions (9). Multi-component interven-
tions may increase the likelihood of having an impact on adher-
ence and treatment outcomes compared with single component
interventions. Researchers may first combine approaches to doc-
ument an effect and in later studies attempt to isolate effects of
intervention features.
We identified only three single component studies with diver-
gent results. Two single component studies found insignificant
effects of the intervention on adherence (13, 14). By contrast,
one single component study found significantly improved adher-
ence in the intervention group (22). In one of the single com-
ponent studies with insignificant results, the lack of effect of the
intervention was attributed to inadequate adherence counseling
techniques of the health care providers who delivered the inter-
vention (13). Although the amount of adherence-related dialog
increased in the intervention group, little of that dialog was prob-
lem solving in nature but tended to have a scolding or lecturing
quality (13).
By contrast, the single component study that yielded improved
levels of adherence in the intervention group mentioned that
participating health care providers had received practice and role-
playing training sessions during which it had been emphasized
that the goal of counseling was to help subjects to improve
their medication-taking behavior, not to scold them about poor
adherence (22). The authors speculated that for patients with
adherence problems, monitoring-informed counseling offered an
opportunity for meaningful discussion about medication-taking
issues specific to the individual and point in time, which may
have provided patients just the focused discussion of behavior
changes that they needed (22). Given the quest for effective and
practical interventions to promote medication adherence (30), it
would bemost interesting to see if future studies employing a sim-
ilar relatively simple monitoring-informed counseling with prior
training of health care providers would also result in improved
adherence.
We aimed to identify study design features that were associ-
ated with larger effect sizes for adherence and virologic treat-
ment response. Lower percentage of patients with undetectable
viral loads at baseline and providing financial incentives for
good adherence were significantly associated with larger effect
sizes for adherence but not for virologic treatment response.
The clinical relevance of these findings is therefore uncertain.
Studies including the didactic provision of information about
HIV, cART, and adherence, or behavioral, cognitive behavioral,
or motivational counseling as intervention components yielded
larger effect sizes for virologic treatment response than studies
that did not include these intervention components. We were
unable to assess the independent effect of these two intervention
components in a multivariate model, due to the low number of
included studies and due to the fact that many studies including
one of the two intervention components also included the other
component. While the multiple component studies were associ-
ated with larger improvements in adherence and virologic treat-
ment response than the single component studies, it remains thus
largely unknown which intervention components are responsible
for this difference.
There is also more a fundamental reason why it could be
difficult to determine which adherence intervention components
are most responsible for improvements in adherence than oth-
ers. It is increasingly recognized that multifactorial barriers may
influence patient adherence and that these barriers may differ
between patients and change within patients over time. There is
also increasing recognition that interventions should be targeted
to people who are clearly identified as needing that specific
intervention. By analogy with a medical condition that can only
be adequately treated when an accurate diagnosis is established,
the treatment, i.e., adherence intervention, should be matched
to the diagnosis, i.e., barriers to adherence that the patient is
experiencing (31). For example, reminder devices are not that
likely to help people whose adherence barriers are not related
to problems remembering doses. Consequently, adherence inter-
vention components that are highly effective for a particular
patient may be largely ineffective for another patient depend-
ing on the specific problems with adherence that a particu-
lar patient is experiencing. The most effective interventions are
probably those that carefully tailor the intervention compo-
nents to the adherence problems that an individual patient is
experiencing.
There has been attention in the field to the content of adherence
care that is provided in control groups of adherence intervention
studies. It was previously found that the difference in adherence
intervention components provided in the intervention and control
groups was a significant predictor of the difference in viral load
and adherence success rates between intervention and control
groups (32). In the present study, the difference in adherence
intervention components provided in the intervention and control
groups was neither a significant predictor of the difference in viro-
logic success nor the difference in adherence between intervention
and control groups (data not shown). This finding may have been
due, however, to a limited description of adherence care provided
to control groups in many of the included studies.
The present study has several limitations. First, because in the
vast majority of studies monitoring-informed counseling was one
out of multiple intervention components, the separate contribu-
tion of such counseling to the improved levels of adherence and
virologic treatment response is difficult to establish.
Second, we searched a single electronic database only, i.e.,
PubMed, which may have resulted in publication bias. However,
we supplemented this database with searches in abstracts of the
most relevant HIV conferences for the subject of medication
adherence.
Third, if studies reported insignificant differences in adher-
ence or virologic response between intervention and control
groups without data, we assumed an effect size of 0.01. This
may have been a too conservative estimate, which may have
resulted in an underestimate of the effectiveness of the concerning
interventions.
Fourth, we categorized adherence intervention components in
several broad categories, for example, behavioral, cognitive behav-
ioral, or motivational counseling. Within these broad categories,
distinct types of intervention components may have had a differ-
ent impact on adherence and virologic response that will remain
undetected in the present global analysis, e.g., cognitive behavioral
Frontiers in Public Health | www.frontiersin.org May 2015 | Volume 3 | Article 1398
Langebeek and Nieuwkerk Meta-analysis of monitoring-informed adherence interventions
counseling could have had a different impact on adherence and
virologic response than motivational interviewing.
Fifth, when more than one type of intervention was tested
within a single study, we considered data from each arm of the
intervention as separate data points. This may have resulted in an
over-representation of a study with more than one intervention
arm. However, a sensitivity analysis in which we excluded this
study from our analysis or included only one of the intervention
arms did not change our overall results.
In conclusion, monitoring-informed counseling improved
medication adherence and virologic response comparedwith con-
trol groups not receiving such counseling in studies inwhich it was
one out of multiple intervention components, but not in studies
where it was the only intervention component.
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